COVID-19: Your Changing Practice

RESOURCES FOR PHYSICIANS

General Info

• Choosing Wisely Canada: COVID-19 Recommendations (for the public and for clinicians)
• Health Canada: Clinical management of patients with COVID-19: Second interim guidance
• Up-to-date info: Public Health Agency of Canada: Coronavirus disease (COVID-19): For health professionals
• Latest news: CMAJ's COVID-19 page

Pre-existing Conditions and COVID-19

• Androgen replacement: Guidance on androgen replacement during COVID-19 crisis
• Diabetes:
  • Diabetes Canada: FAQ about COVID-19 and diabetes
  • Association of British Clinical Diabetologists (ABCD): COVID-19 resources for proofessionals
  • COVID-19 and childhood diabetes
  • Coronavirus + Diabetes
  • University of Toronto, Family & Community Medicine: Managing type 2 diabetes during COVID-19: a guide for primary care providers
• Diabetes insipidus: Society for Endocrinology: Endocrinology in the time of COVID-19: Management of hyponatraemia and diabetes insipidus
• Fertility treatment: Template for advising patients receiving treatment for male infertility
• Genetic haemochromatosis: Haemochromatosis UK: Guidance for people with genetic haemochromatosis during COVID-19 pandemic
• Growth hormone: Guidance on adult growth hormone (GH) replacement therapy during the COVID-19 pandemic
• Neuroendocrine tumours: COVID-19 pandemic strategy for the interim management of patients with neuroendocrine tumours/neuroendocrine cancer
• Osteoporosis and calcium disorders:
  • Society for Endocrinology: Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis
  • LETTER TEMPLATE - Continuation of denosumab (Prolia®) injection during the COVID-19 pandemic (hospital administration)
  • LETTER TEMPLATE - Self-administration of denosumab (Prolia®) during the COVID-19 pandemic
  • LETTER TEMPLATE - Postponement of zoledronic acid infusions
  • Royal Osteoporosis Society (UK): Advice and information page for osteoporosis
• Parathyroid: Parathyroid UK: Coronavirus (COVID-19) and parathyroid conditions FAQs
• Pituitary/adrenal insufficiency:
  • Royal College of Physicians (UK): Guidance for the prevention and emergency management of adult patients with adrenal insufficiency
  • National Adrenal Diseases Foundation: COVID-19 – Adrenal Insufficiency and Steroid Dosing Guidelines
  • Canadian Addison Society:
    • National Adrenal Crisis Emergency Cards (bilingual)
    • Links about adrenal insufficiency and coronavirus
  • Addison's Self-Help Group (UK):
    • COVID-19: Clinical Management guidance: Adrenal Insufficiency
    • Emergency Training video: Solu-Cortef, Act-o-Vial safety syringe emergency injection
  • Society for Endocrinology:
    • Advice for patients who take replacement steroids (hydrocortisone, prednisolone, dexamethasone or plenadren) for pituitary/adrenal insufficiency
    • Endocrinology in the time of COVID-19: Management of adrenal insufficiency
    • Endocrinology in the time of COVID-19: Management of Cushing's syndrome
  • Pituitary Foundation (UK): Hydrocortisone advice for parents leaflet
• Pituitary tumours:
  • Society for Endocrinology: Endocrinology in the time of COVID-19: Management of pituitary tumours
• Thyroid dysfunction:
  • BTA/SFE statement regarding issues specific to thyroid dysfunction during the COVID-19 pandemic
  • Resource-limited treatment of thyrotoxicosis during the COVID-19 pandemic
  • LETTER TEMPLATE - Cancellation of your radioactive iodine treatment (131-I) for hyperthyroidism
  • JCEM: Subacute thyroiditis after Sars-COV-2 infection
• Thyroid cancer:
  • BTA/SFE advice for patients with thyroid cancer during the COVID-19 pandemic
  • LETTER TEMPLATE - Thyroid cancer: radioactive iodine rreatment during COVID-19 pandemic

Kids with Endocrine Conditions and School:

• Canadian School Boards Association: Reopening of schools post COVID-19
• BC Centre for Disease Control: COVID-19 public health guidance for K–12 school settings
• BC Children's Hospital: COVID-19 and adrenal insufficiency
• Canadian Paediatric Society: CPS supports a safe return to school for Canada’s children and youth
• diabetes@school: Type 1 diabetes and COVID-19: going back to school

Practice Issues

• Canadian Medical Protective Association COVID-19: Scope of practice, virtual care or medical legal issues
• Royal College of Physicians and Surgeons of Canada: Telemedicine and virtual care guidelines (and other clinical resources for COVID-19)
• Canadian Medical Association:
  • How to set up virtual care in your practice
  • Policy: Framework for ethical decision-making during the coronavirus pandemic

Health and Wellness

• Canadian Medical Protective Association: Resources for staying well during COVID-19
• Canadian Medical Association:
  • A clinician’s guide: Managing COVID-19 stress and anxiety
  • Maintaining your and your family’s well-being during a pandemic

Financial Matters

• Canada Revenue Agency: COVID-19: Changes to Canadian taxes and benefits
• MD Financial Management: Here for you during COVID-19